{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T23:17:10Z","timestamp":1784330230125,"version":"3.55.0"},"reference-count":33,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2010,1,1]],"date-time":"2010-01-01T00:00:00Z","timestamp":1262304000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["The American Journal of the Medical Sciences"],"published-print":{"date-parts":[[2010,1]]},"DOI":"10.1097\/maj.0b013e3181bbb647","type":"journal-article","created":{"date-parts":[[2009,12,30]],"date-time":"2009-12-30T08:25:12Z","timestamp":1262161512000},"page":"15-21","source":"Crossref","is-referenced-by-count":26,"title":["Prognostic Significance of Serum Uric Acid in Patients Admitted to the Department of Medicine"],"prefix":"10.1016","volume":"339","author":[{"given":"Asaf","family":"Wasserman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matti","family":"Shnell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ben","family":"Boursi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanan","family":"Guzner-Gur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1097\/MAJ.0b013e3181bbb647_bb0005","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1038\/nature01991","article-title":"Molecular identification of a danger signal that stress the immune system to dying cells","volume":"425","author":"Shy","year":"2003","journal-title":"Nature"},{"key":"10.1097\/MAJ.0b013e3181bbb647_bb0010","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1161\/01.HYP.0000072820.07472.3B","article-title":"Uric acid stimulates monocyte chemoattractant protein-1 production in vascular smooth muscle cells via mitogen-activated protein kinase and cyclooxygenases-2","volume":"41","author":"Kanellis","year":"2003","journal-title":"Hypertension"},{"key":"10.1097\/MAJ.0b013e3181bbb647_bb0015","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1042\/bj3400143","article-title":"When and why a water-soluble antioxidant becomes pro-oxidant during copper-induced low-density lipoprotein oxidation: a study using uric acid","volume":"340","author":"Bagnati","year":"1999","journal-title":"Biochem J"},{"key":"10.1097\/MAJ.0b013e3181bbb647_bb0020","doi-asserted-by":"crossref","first-page":"8604","DOI":"10.1016\/S0021-9258(18)93017-6","article-title":"Uric acid stimulates vascular smooth muscle proliferation by increasing platelets derived growth factor A chain expression","volume":"266","author":"Rao","year":"1991","journal-title":"J Biol Chem"},{"key":"10.1097\/MAJ.0b013e3181bbb647_bb0025","doi-asserted-by":"crossref","first-page":"1739","DOI":"10.1111\/j.1523-1755.2005.00273.x","article-title":"Hyperuricemia induces endothelial dysfunction","volume":"67","author":"Khosla","year":"2005","journal-title":"Kidney Int"},{"key":"10.1097\/MAJ.0b013e3181bbb647_bb0030","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1007\/s11906-006-0006-y","article-title":"Uric acid and the vasculature","volume":"8","author":"Corry","year":"2006","journal-title":"Curr Hypertens Res"},{"key":"10.1097\/MAJ.0b013e3181bbb647_bb0035","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1111\/j.1749-6632.1996.tb33318.x","article-title":"Identification of uric acid in aortic aneurysm and atherosclerotic artery","volume":"800","author":"Patetsios","year":"1996","journal-title":"Ann NY Acad Sci"},{"key":"10.1097\/MAJ.0b013e3181bbb647_bb0040","doi-asserted-by":"crossref","first-page":"2404","DOI":"10.1001\/jama.283.18.2404","article-title":"Serum uric acid and cardiovascular mortality; the NHANES I epidemiologic follow-up study, 1971-1992. National Health and Nutrition Examination Survey","volume":"283","author":"Fang","year":"2003","journal-title":"JAMA"},{"key":"10.1097\/MAJ.0b013e3181bbb647_bb0045","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1097\/00001648-199907000-00009","article-title":"Association of serum uric acid with all cause and cardiovascular disease mortality and incident myocardial infarction in the MONICA Augsburg cohort; WHO Monitoring Trends and Determinants in Cardiovascular Diseases","volume":"10","author":"Liese","year":"1999","journal-title":"Epidemiology"},{"key":"10.1097\/MAJ.0b013e3181bbb647_bb0050","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1161\/01.HYP.36.6.1072","article-title":"Relation between serum uric acid and risk of cardiovascular disease in essential hypertension: the PIUMA study","volume":"36","author":"Verdecchia","year":"2000","journal-title":"Hypertension"},{"key":"10.1097\/MAJ.0b013e3181bbb647_bb0055","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1161\/01.HYP.37.4.1069","article-title":"Prognostic significance of serum creatinine and uric acid in older Chinese patients with isolated systolic hypertension","volume":"36","author":"Wang","year":"2001","journal-title":"Hypertension"},{"key":"10.1097\/MAJ.0b013e3181bbb647_bb0060","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1097\/00004872-200018080-00021","article-title":"Serum uric acid, diuretic treatment and risk of cardiovascular events in Systolic Hypertension in the Elderly Program (SHEP)","volume":"18","author":"Franse","year":"2000","journal-title":"J Hypertens"},{"key":"10.1097\/MAJ.0b013e3181bbb647_bb0065","doi-asserted-by":"crossref","first-page":"1546","DOI":"10.1001\/archinte.164.14.1546","article-title":"Uric acid level as a risk factor for cardiovascular and all cause mortality in middle-aged men: a prospective cohort study","volume":"164","author":"Niskanen","year":"2004","journal-title":"Arch Intern Med."},{"key":"10.1097\/MAJ.0b013e3181bbb647_bb0070","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1113\/jphysiol.2003.055913","article-title":"Xanthine oxidoreductase and cardiovascular disease: molecular mechanisms and pathophysiological implications","volume":"555","author":"Berry","year":"2004","journal-title":"J Physiol"},{"key":"10.1097\/MAJ.0b013e3181bbb647_bb0075","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1136\/hrt.2006.090845","article-title":"Increased levels of uric acid predict haemodynamic compromise in patients with heart failure independently of B-type natriuretic peptide levels","volume":"93","author":"Kittleson","year":"2007","journal-title":"Heart"},{"key":"10.1097\/MAJ.0b013e3181bbb647_bb0080","doi-asserted-by":"crossref","first-page":"1991","DOI":"10.1161\/01.CIR.0000065637.10517.A0","article-title":"Uric acid and survival in chronic heart failure: validation and application in metabolic function, and hemodynamic staging","volume":"107","author":"Anker","year":"2003","journal-title":"Circulation"},{"key":"10.1097\/MAJ.0b013e3181bbb647_bb0085","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1007\/s11739-008-0141-3","article-title":"The conundrum of hyperuricemia, metabolic syndrome, and renal disease","volume":"3","author":"Nakagawa","year":"2008","journal-title":"Intern Emerg Med"},{"key":"10.1097\/MAJ.0b013e3181bbb647_bb0090","doi-asserted-by":"crossref","first-page":"1908","DOI":"10.1038\/ki.1997.260","article-title":"Predictors of the progression of renal disease in the Modification of Diet in Renal Disease Study","volume":"51","author":"Hunsicker","year":"1997","journal-title":"Kidney Int"},{"key":"10.1097\/MAJ.0b013e3181bbb647_bb0095","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1291\/hypres.24.691","article-title":"Significance of hyperuricemia on the early detection of renal failure in a cohort of screened subjects","volume":"24","author":"Iseki","year":"2001","journal-title":"Hypertens Res"},{"key":"10.1097\/MAJ.0b013e3181bbb647_bb0100","doi-asserted-by":"crossref","first-page":"2981","DOI":"10.1001\/jama.288.23.2981","article-title":"Major outcomes in high risk hypertensive patients randomized to angiotensinconverting enzyme inhibitor or calcium channel blocker vs diuretics: the hypertensive, lipid lowering treatment to prevent heart attack trial (ALLHAT)","volume":"288","author":"Black","year":"2002","journal-title":"JAMA"},{"key":"10.1097\/MAJ.0b013e3181bbb647_bb0105","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1016\/S0140-6736(00)02527-7","article-title":"Morbidity and morality in patients randomized to double-blind treatment with a long-acting calcium-channel blocker or diuretic in the International Nifedipine GITS Study: intervention as a goal in hypertension treatment (INSIGHT)","volume":"356","author":"Brown","year":"2000","journal-title":"Lancet"},{"key":"10.1097\/MAJ.0b013e3181bbb647_bb0110","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1111\/j.1523-1755.2004.00484.x","article-title":"The impact of serum uric acid on cardiovascular outcome in the LIFE study","volume":"65","author":"Hoieggen","year":"2004","journal-title":"Kidney Int"},{"key":"10.1097\/MAJ.0b013e3181bbb647_bb0115","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1016\/j.ahj.2004.04.005","article-title":"Effect of statin treatment on uric acid homeostasis in patients with primary hyperlipidemia","volume":"148","author":"Milionis","year":"2004","journal-title":"Am Heart J"},{"key":"10.1097\/MAJ.0b013e3181bbb647_bb0120","doi-asserted-by":"crossref","first-page":"2148","DOI":"10.1056\/NEJMra0800239","article-title":"Biomarkers in heart failure","volume":"358","author":"Braunwald","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1097\/MAJ.0b013e3181bbb647_bb0125","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1002\/art.23121","article-title":"Serum uric acid is an independent predictor of all cause mortality in patients at high risk of cardiovascular disease","volume":"58","author":"Ioachimescu","year":"2008","journal-title":"Arthritis Rheum"},{"key":"10.1097\/MAJ.0b013e3181bbb647_bb0130","doi-asserted-by":"crossref","first-page":"1424","DOI":"10.1161\/CIRCULATIONAHA.105.584102","article-title":"The Seattle heart failure model: prediction of survival in heart failure","volume":"113","author":"Levy","year":"2006","journal-title":"Circulation"},{"key":"10.1097\/MAJ.0b013e3181bbb647_bb0135","doi-asserted-by":"crossref","first-page":"1811","DOI":"10.1056\/NEJMra0800885","article-title":"Uric acid and cardiovascular risk","volume":"359","author":"Feig","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1097\/MAJ.0b013e3181bbb647_bb0140","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1097\/MAJ.0b013e31818af6de","article-title":"Diagnostic and prognostic significance of serum CRP levels in patients admitted to the department of medicine","volume":"337","author":"Keshet","year":"2009","journal-title":"Am J Med Sci"},{"key":"10.1097\/MAJ.0b013e3181bbb647_bb0145","doi-asserted-by":"crossref","first-page":"2301","DOI":"10.1016\/j.jacc.2008.01.068","article-title":"Impact of oxypurinol in patients with symptomatic heart failure: results of the OPT-CHF study","volume":"51","author":"Hare","year":"2008","journal-title":"J Am Coll Cardiol"},{"key":"10.1097\/MAJ.0b013e3181bbb647_bb0150","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1038\/ajh.2008.289","article-title":"Serum uric acid levels in preeclampsia","volume":"21","author":"Tsukimori","year":"2008","journal-title":"Am J Hypertens"},{"key":"10.1097\/MAJ.0b013e3181bbb647_bb0155","doi-asserted-by":"crossref","first-page":"2508","DOI":"10.1161\/CIRCULATIONAHA.106.651117","article-title":"High-dose allopurinol improves endothelial dysfunction by profoundly reducing vascular oxidative stress and not by lowering uric acid","volume":"114","author":"George","year":"2006","journal-title":"Circulation"},{"key":"10.1097\/MAJ.0b013e3181bbb647_bb0160","doi-asserted-by":"crossref","first-page":"3127","DOI":"10.2337\/db06-0283","article-title":"Uric acid restores endothelial function in patients with type l diabetes and regular smokers","volume":"55","author":"Waring","year":"2006","journal-title":"Diabetes"},{"key":"10.1097\/MAJ.0b013e3181bbb647_bb0165","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1056\/NEJMoa041031","article-title":"Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization","volume":"351","author":"Go","year":"2004","journal-title":"N Engl J Med"}],"container-title":["The American Journal of the Medical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002962915317110?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002962915317110?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,10,19]],"date-time":"2021-10-19T17:35:07Z","timestamp":1634664907000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002962915317110"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,1]]},"references-count":33,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2010,1]]}},"alternative-id":["S0002962915317110"],"URL":"https:\/\/doi.org\/10.1097\/maj.0b013e3181bbb647","relation":{},"ISSN":["0002-9629"],"issn-type":[{"value":"0002-9629","type":"print"}],"subject":[],"published":{"date-parts":[[2010,1]]}}}